BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33518637)

  • 1. [Potential for Big Data Analysis Using AI in the Field of Clinical Pharmacy].
    Kiryu Y
    Yakugaku Zasshi; 2021; 141(2):179-185. PubMed ID: 33518637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical Big Data Analysis Using Machine Learning Algorithms in the Field of Clinical Pharmacy].
    Kiryu Y
    Yakugaku Zasshi; 2022; 142(4):319-326. PubMed ID: 35370185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of a Medical Big Data Analysis System Utilizing Artificial Intelligence Analytics in Clinical Pharmacy].
    Kiryu Y
    Yakugaku Zasshi; 2023; 143(6):501-505. PubMed ID: 37258183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of Clinical Pharmaceutical Services via Artificial Intelligence Adaptation].
    Sato H
    Yakugaku Zasshi; 2022; 142(4):337-340. PubMed ID: 35370188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Literacy for Appropriate Use of Medical Big Data and Artificial Intelligence].
    Sakai T
    Yakugaku Zasshi; 2023; 143(6):491-495. PubMed ID: 37258181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Artificial Intelligence and Machine Learning in Drug Discovery.
    Gupta RR
    Methods Mol Biol; 2022; 2390():113-124. PubMed ID: 34731466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial Intelligence and Quantum Computing as the Next Pharma Disruptors.
    Cova T; Vitorino C; Ferreira M; Nunes S; Rondon-Villarreal P; Pais A
    Methods Mol Biol; 2022; 2390():321-347. PubMed ID: 34731476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.
    Tripathi N; Goshisht MK; Sahu SK; Arora C
    Mol Divers; 2021 Aug; 25(3):1643-1664. PubMed ID: 34110579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role and Applicability of Spontaneous Reporting Databases in Medical Big Data].
    Sakai T
    Yakugaku Zasshi; 2021; 141(2):165-168. PubMed ID: 33518634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Big Data Is Not Yet Available: Why We Need Realism Rather than Exaggeration.
    Kim HS; Kim DJ; Yoon KH
    Endocrinol Metab (Seoul); 2019 Dec; 34(4):349-354. PubMed ID: 31884734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD).
    Lee JW; Maria-Solano MA; Vu TNL; Yoon S; Choi S
    Biochem Soc Trans; 2022 Feb; 50(1):241-252. PubMed ID: 35076690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy.
    Del Rio-Bermudez C; Medrano IH; Yebes L; Poveda JL
    J Pharm Policy Pract; 2020 Nov; 13(1):75. PubMed ID: 33292570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial Intelligence Within Pharmacovigilance: A Means to Identify Cognitive Services and the Framework for Their Validation.
    Mockute R; Desai S; Perera S; Assuncao B; Danysz K; Tetarenko N; Gaddam D; Abatemarco D; Widdowson M; Beauchamp S; Cicirello S; Mingle E
    Pharmaceut Med; 2019 Apr; 33(2):109-120. PubMed ID: 31933254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making Sense of Pharmacovigilance and Drug Adverse Event Reporting: Comparative Similarity Association Analysis Using AI Machine Learning Algorithms in Dogs and Cats.
    Xu X; Mazloom R; Goligerdian A; Staley J; Amini M; Wyckoff GJ; Riviere J; Jaberi-Douraki M
    Top Companion Anim Med; 2019 Dec; 37():100366. PubMed ID: 31837760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Artificial and Human Intelligence: A Partnership for Responsible Innovation in Biomedical Engineering and Medicine.
    Dzobo K; Adotey S; Thomford NE; Dzobo W
    OMICS; 2020 May; 24(5):247-263. PubMed ID: 31313972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality evaluation of the Japanese Adverse Drug Event Report database (JADER).
    Tsuchiya M; Obara T; Sakai T; Nomura K; Takamura C; Mano N
    Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):173-181. PubMed ID: 31823506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Artificial Intelligence in Drug Discovery.
    Chopra H; Baig AA; Gautam RK; Kamal MA
    Curr Pharm Des; 2022; 28(33):2690-2703. PubMed ID: 35676841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Big Data, AI and Machine Learning for Precision Psychiatry: How are they changing the clinical practice?].
    Winter NR; Hahn T
    Fortschr Neurol Psychiatr; 2020 Nov; 88(12):786-793. PubMed ID: 32998163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Intelligence and Arthroplasty at a Single Institution: Real-World Applications of Machine Learning to Big Data, Value-Based Care, Mobile Health, and Remote Patient Monitoring.
    Ramkumar PN; Haeberle HS; Bloomfield MR; Schaffer JL; Kamath AF; Patterson BM; Krebs VE
    J Arthroplasty; 2019 Oct; 34(10):2204-2209. PubMed ID: 31280916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.